Total Liabilities Summary of Yuhan Corporation

Yuhan Corporation's latest annual total liabilities in 2023 was 712.33 Billion KRW , up 53.22% from previous year.
Yuhan Corporation's latest quarterly total liabilities in 2024 Q1 was 712.58 Billion KRW , down 0.0% from previous quarter.
Yuhan Corporation reported annual total liabilities of 464.92 Billion KRW in 2022, down -11.93% from previous year.
Yuhan Corporation reported annual total liabilities of 527.92 Billion KRW in 2021, down -3.49% from previous year.
Yuhan Corporation reported quarterly total liabilities of 712.58 Billion KRW for 2024 Q1, down 0.0% from previous quarter.
Yuhan Corporation reported quarterly total liabilities of - KRW for 2023 Q4, down -100.0% from previous quarter.

Annual Total Liabilities Chart of Yuhan Corporation (2023 - 2007)

Historical Annual Total Liabilities of Yuhan Corporation (2023 - 2007)

Year	Total Liabilities	Total Liabilities Growth
2023	712.33 Billion KRW	53.22%
2022	464.92 Billion KRW	-11.93%
2021	527.92 Billion KRW	-3.49%
2020	547.01 Billion KRW	17.08%
2019	467.2 Billion KRW	-10.51%
2018	522.07 Billion KRW	6.91%
2017	488.34 Billion KRW	-11.11%
2016	549.38 Billion KRW	6.39%
2015	516.38 Billion KRW	51.83%
2014	340.1 Billion KRW	19.03%
2013	285.72 Billion KRW	32.98%
2012	214.86 Billion KRW	8.88%
2011	197.34 Billion KRW	7.96%
2010	182.78 Billion KRW	9.4%
2009	167.08 Billion KRW	-5.22%
2008	176.29 Billion KRW	-26.77%
2007	240.73 Billion KRW	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	770.57 Billion KRW	8.14%
2024 Q1	712.58 Billion KRW	0.0%
2023 Q4	- KRW	-100.0%
2023 Q2	521.82 Billion KRW	5.57%
2023 Q1	494.28 Billion KRW	6.32%
2023 FY	712.33 Billion KRW	53.22%
2023 Q3	635.53 Billion KRW	21.79%
2022 Q4	464.92 Billion KRW	-2.91%
2022 Q2	523.24 Billion KRW	-8.12%
2022 Q3	478.85 Billion KRW	-8.48%
2022 Q1	569.49 Billion KRW	7.87%
2022 FY	464.92 Billion KRW	-11.93%
2021 Q3	547.75 Billion KRW	-3.43%
2021 FY	527.92 Billion KRW	-3.49%
2021 Q1	650.62 Billion KRW	18.94%
2021 Q4	527.92 Billion KRW	-3.62%
2021 Q2	567.22 Billion KRW	-12.82%
2020 Q3	537.86 Billion KRW	-8.29%
2020 Q1	518.66 Billion KRW	11.01%
2020 Q2	586.45 Billion KRW	13.07%
2020 Q4	547.01 Billion KRW	1.7%
2020 FY	547.01 Billion KRW	17.08%
2019 Q3	485.98 Billion KRW	5.23%
2019 Q1	598.38 Billion KRW	14.62%
2019 Q4	467.2 Billion KRW	-3.86%
2019 FY	467.2 Billion KRW	-10.51%
2019 Q2	461.85 Billion KRW	-22.82%
2018 Q3	520.13 Billion KRW	-4.23%
2018 FY	522.07 Billion KRW	6.91%
2018 Q1	542.43 Billion KRW	11.08%
2018 Q2	543.1 Billion KRW	0.12%
2018 Q4	522.07 Billion KRW	0.37%
2017 Q4	488.34 Billion KRW	-3.5%
2017 FY	488.34 Billion KRW	-11.11%
2017 Q1	557.29 Billion KRW	1.44%
2017 Q2	515.06 Billion KRW	-7.58%
2017 Q3	506.05 Billion KRW	-1.75%
2016 FY	549.38 Billion KRW	6.39%
2016 Q4	549.38 Billion KRW	-5.51%
2016 Q3	581.41 Billion KRW	-3.12%
2016 Q2	600.14 Billion KRW	13.66%
2016 Q1	527.99 Billion KRW	2.25%
2015 Q3	417.42 Billion KRW	0.24%
2015 Q2	416.43 Billion KRW	9.5%
2015 FY	516.38 Billion KRW	51.83%
2015 Q1	380.3 Billion KRW	11.82%
2015 Q4	516.38 Billion KRW	23.71%
2014 Q3	289.07 Billion KRW	1.25%
2014 FY	340.1 Billion KRW	19.03%
2014 Q1	289.46 Billion KRW	1.31%
2014 Q2	285.5 Billion KRW	-1.37%
2014 Q4	340.1 Billion KRW	17.65%
2013 Q4	285.72 Billion KRW	6.35%
2013 Q1	251.91 Billion KRW	17.24%
2013 FY	285.72 Billion KRW	32.98%
2013 Q2	251.48 Billion KRW	-0.17%
2013 Q3	268.65 Billion KRW	6.83%
2012 Q1	178.66 Billion KRW	0.0%
2012 FY	214.86 Billion KRW	8.88%
2012 Q4	214.86 Billion KRW	2.66%
2012 Q3	209.29 Billion KRW	-6.31%
2012 Q2	223.39 Billion KRW	25.03%
2011 Q1	166.55 Billion KRW	-2.44%
2011 Q2	172.16 Billion KRW	3.37%
2011 FY	197.34 Billion KRW	7.96%
2011 Q3	174.57 Billion KRW	1.4%
2010 Q4	170.71 Billion KRW	5.32%
2010 Q1	159.46 Billion KRW	7.65%
2010 Q2	166.4 Billion KRW	4.35%
2010 FY	182.78 Billion KRW	9.4%
2010 Q3	162.08 Billion KRW	-2.59%
2009 Q2	156.98 Billion KRW	-4.23%
2009 Q1	163.92 Billion KRW	12.77%
2009 FY	167.08 Billion KRW	-5.22%
2009 Q4	148.14 Billion KRW	4.13%
2009 Q3	142.26 Billion KRW	-9.38%
2008 Q1	226.45 Billion KRW	14.42%
2008 Q3	159.76 Billion KRW	-28.39%
2008 FY	176.29 Billion KRW	-26.77%
2008 Q4	145.36 Billion KRW	-9.02%
2008 Q2	223.09 Billion KRW	-1.48%
2007 Q3	221.6 Billion KRW	-4.08%
2007 Q1	261.33 Billion KRW	0.0%
2007 Q2	231.03 Billion KRW	-11.6%
2007 FY	240.73 Billion KRW	0.0%
2007 Q4	197.91 Billion KRW	-10.69%

Peer Total Liabilities Comparison of Yuhan Corporation

Name	Total Liabilities	Total Liabilities Difference
Yuyu Pharma, Inc.	77.85 Billion KRW	-814.921%
Dong-A Socio Holdings Co., Ltd.	929.79 Billion KRW	23.388%
Ildong Holdings Co., Ltd.	707.09 Billion KRW	-0.741%
HANDOK Inc.	449.7 Billion KRW	-58.401%
Kukje Pharma Co., Ltd.	85.67 Billion KRW	-731.487%
Dong-A ST Co., Ltd.	631.91 Billion KRW	-12.727%
SAMSUNG PHARM. Co., LTD.	15.89 Billion KRW	-4381.667%
Hanmi Pharm. Co., Ltd.	851.82 Billion KRW	16.375%
Hanall Biopharma Co.,Ltd	53.52 Billion KRW	-1230.761%
Ilyang Pharmaceutical Co.,Ltd	205.87 Billion KRW	-246.004%
Dong Sung Bio Pharm.Co.,Ltd.	75.17 Billion KRW	-847.624%
MYUNGMOON Pharm co.,Ltd	147.79 Billion KRW	-381.979%
Hana Pharm Co., Ltd.	70.4 Billion KRW	-911.825%
Yuyu Pharma, Inc.	77.85 Billion KRW	-814.921%
Ilsung Pharmaceuticals Co., Ltd.	36.43 Billion KRW	-1855.025%
REYON Pharmaceutical Co., Ltd.	251.15 Billion KRW	-183.629%
Aprogen pharmaceuticals,Inc.	220.7 Billion KRW	-222.755%
JW Holdings Corporation	827.51 Billion KRW	13.918%
Ildong Pharmaceutical Co., Ltd.	436.99 Billion KRW	-63.008%
Chong Kun Dang Pharmaceutical Corp.	586.79 Billion KRW	-21.395%
JW Pharmaceutical Corporation	379.59 Billion KRW	-87.656%
Shin Poong Pharm.Co.,Ltd.	79.3 Billion KRW	-798.265%
Hyundai Pharmaceutical Co., Ltd.	69.96 Billion KRW	-918.096%
Samil Pharmaceutical Co.,Ltd	242.85 Billion KRW	-193.321%
Jeil Pharmaceutical Co.,Ltd	330.29 Billion KRW	-115.668%
Yuyu Pharma, Inc.	77.85 Billion KRW	-814.921%
Kwang Dong Pharmaceutical Co., Ltd.	490.01 Billion KRW	-45.37%
Daewoong pharmaceutical Co.,Ltd	858.02 Billion KRW	16.98%
JW Pharmaceutical Corporation	379.59 Billion KRW	-87.656%
Yuhan Corporation	712.33 Billion KRW	0.0%
Jeil Pharma Holdings Inc	477.81 Billion KRW	-49.084%
Yungjin Pharm. Co., Ltd.	136.96 Billion KRW	-420.074%
Suheung Co., Ltd.	516.66 Billion KRW	-37.871%
JW Pharmaceutical Corporation	379.59 Billion KRW	-87.656%
Samjin Pharmaceuticals Co., Ltd.	154.53 Billion KRW	-360.952%
Korea United Pharm Inc.	89.96 Billion KRW	-691.792%
CKD Bio Corp.	170.76 Billion KRW	-317.156%
Daewon Pharmaceutical Co., Ltd.	243.73 Billion KRW	-192.261%
Dongwha Pharm.Co.,Ltd	157.65 Billion KRW	-351.828%
Whan In Pharm Co.,Ltd.	43.01 Billion KRW	-1555.862%
Shin Poong Pharm.Co.,Ltd.	79.3 Billion KRW	-798.265%
Chong Kun Dang Holdings Corp.	632.51 Billion KRW	-12.619%
Boryung Corporation	373.1 Billion KRW	-90.92%
Bukwang Pharmaceutical Co., Ltd.	208.19 Billion KRW	-242.146%
Ilyang Pharmaceutical Co.,Ltd	205.87 Billion KRW	-246.004%
JW Lifescience Corporation	96.44 Billion KRW	-638.608%

Global Stocks Search

Yuhan Corporation (000105.KS)

Total Liabilities Summary of Yuhan Corporation

Annual Total Liabilities Chart of Yuhan Corporation (2023 - 2007)

Historical Annual Total Liabilities of Yuhan Corporation (2023 - 2007)

Peer Total Liabilities Comparison of Yuhan Corporation